Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 17, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 17, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 26, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 30, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 26, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 19, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 19, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 21, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 21, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 21, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 2, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 2, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 16, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 21, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 21, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 1, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 13, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 6, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 6, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 6, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 6, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 6, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 6, 2022 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| May 6, 2022 | PBMR | Z | WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST | Loading... |
| May 2, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 2, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 2, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 2, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 2, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 2, 2022 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| May 2, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 29, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 29, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 29, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 29, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccines; pharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; diagnostic products, preparations and agents for medicinal purposes
Class 042
Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells
Additional Information
Design Mark
The mark consists of an incomplete open circle which is partially bisected by four lines forming an open triangle and incomplete open triangle, where each of the four lines are connected by filled circles; the word "eikon" is immediately adjacent and over the word "therapeutics".
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"